HB 592-FN (2022): requiring bond from pharmaceutical companies providing vaccines.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“HB 592-FN (2022): requiring bond from pharmaceutical companies providing vaccines.” Granite Record, https://graniterecord.org/bill/2022/hb592. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). HB 592-FN (2022): requiring bond from pharmaceutical companies providing vaccines. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2022/hb592
Chicago
Granite Record. “HB 592-FN (2022): requiring bond from pharmaceutical companies providing vaccines.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2022/hb592.
BibTeX
@misc{bill-2022-hb592, title = {HB 592-FN (2022): requiring bond from pharmaceutical companies providing vaccines.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2022/hb592}, note = {Accessed 24 Oct. 2026} }

HB 592-FN (2022)

requiring bond from pharmaceutical companies providing vaccines.

  • Status: Referred for interim study
  • Term: 2021-2022
  • House committee: Commerce and Consumer Affairs
  • Subject: Public and Mental Health

The Story

It was introduced on January 6, 2021 and referred to the House Commerce and Consumer Affairs committee. The committee met in executive session on March 2, 2021 and March 3, 2021. The committee retained the bill, holding it for further work rather than reporting it out this year. The committee held work sessions on September 21, 2021 and October 12, 2021. The committee met in executive session on October 26, 2021 to vote on its recommendation. The majority recommended that the House study it after the session ends, and the minority recommended that the House kill it, by a vote of 10–9. The report was placed on the regular calendar. On January 5, 2022 the House voted to study it after the session ends on a division vote 168–167. The committee held a work session on October 13, 2022. The committee met in executive session on October 19, 2022 to vote on its recommendation. The committee reported back on its interim study of the bill: “Not Recommended for Future Legislation”, by a vote of 16 to 1.

Sponsors

Hearings and Sessions

  • February 3, 2021, 2:45 PM: public hearing, House Commerce and Consumer Affairs
  • March 2, 2021, 9:00 AM: executive session, House Commerce and Consumer Affairs
  • March 3, 2021, 1:30 PM: executive session, House Commerce and Consumer Affairs
  • September 21, 2021, 2:30 PM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302-304
  • October 12, 2021, 9:00 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 301-303
  • October 26, 2021, 10:00 AM: executive session, House Commerce and Consumer Affairs, LOB306-308
  • October 13, 2022, 2:00 PM: full committee work session, House Commerce and Consumer Affairs, LOB 302-304
  • October 19, 2022, 10:00 AM: executive session, House Commerce and Consumer Affairs, LOB 302-304

Votes

  • January 5, 2022, House: Refer for Interim Study — yeas 168, nays 167, passed

The Docket

  • January 6, 2021: Introduced (in recess of) 01/06/2021 and referred to Commerce and Consumer Affairs
  • February 3, 2021: Public Hearing: 02/03/2021 02:45 pm Members of the public may attend using the following link: To join the webinar: https://www.zoom.us/j/91813981191 / Executive session on pending legislation may be held throughout the day (time permitting) from the time the committee is initially convened
  • March 2, 2021: Executive Session: 03/02/2021 09:00 am Members of the public may attend using the following link: To join the webinar: https://www.zoom.us/j/95215897452
  • March 3, 2021: Executive Session: 03/03/2021 01:30 pm Members of the public may attend using the following link: To join the webinar: https://www.zoom.us/j/98917516497 (if necessary)
  • March 9, 2021: Retained in Committee
  • September 21, 2021: Subcommittee Work Session: 09/21/2021 02:30 pm LOB 302-304
  • October 12, 2021: Subcommittee Work Session: 10/12/2021 09:00 am LOB 301-303
  • October 26, 2021: Executive Session: 10/26/2021 10:00 a.m. LOB306-308
  • October 29, 2021: Majority Committee Report: Refer for Interim Study HB592-FN 10/29/2021 (Vote 10-9; RC)
  • November 15, 2021: Minority Committee Report: Inexpedient to Legislate
  • January 5, 2022: Refer for Interim Study: MA DV 168-167 01/05/2022
  • October 13, 2022: Full Committee Work Session: 10/13/2022 02:00 pm LOB 302-304
  • October 19, 2022: Executive Session: 10/19/2022 10:00 am LOB 302-304
  • October 27, 2022: Interim Study Report: Not Recommended for Future Legislation (Vote 16-1)

Laws It Would Change

From the General Court